Mink Long Term Debt from 2010 to 2024
| INKT Stock | USD 0.69 0.01 1.47% |
Long Term Debt | First Reported 2010-12-31 | Previous Quarter 50.4 M | Current Value 38.8 M | Quarterly Volatility 8.7 M |
Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 584.4 K, Depreciation And Amortization of 118.7 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 0.0355, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.
Mink | Long Term Debt |
Latest Mink Therapeutics' Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of Mink Therapeutics over the last few years. Long-term debt is a debt that Mink Therapeutics has held for over one year. Long-term debt appears on Mink Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Mink Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Mink Therapeutics' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mink Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Long Term Debt | 10 Years Trend |
|
Long Term Debt |
| Timeline |
Mink Long Term Debt Regression Statistics
| Arithmetic Mean | 32,574,103 | |
| Geometric Mean | 31,606,248 | |
| Coefficient Of Variation | 26.85 | |
| Mean Deviation | 7,711,601 | |
| Median | 26,790,402 | |
| Standard Deviation | 8,746,857 | |
| Sample Variance | 76.5T | |
| Range | 23.6M | |
| R-Value | 0.79 | |
| Mean Square Error | 31.5T | |
| R-Squared | 0.62 | |
| Significance | 0.0005 | |
| Slope | 1,537,068 | |
| Total Sum of Squares | 1071.1T |
Mink Long Term Debt History
Other Fundumenentals of Mink Therapeutics
Mink Therapeutics Long Term Debt component correlations
Click cells to compare fundamentals
About Mink Therapeutics Financial Statements
Mink Therapeutics shareholders use historical fundamental indicators, such as Long Term Debt, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Mink Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Mink Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 50.4 M | 38.8 M | |
| Long Term Debt | 50.4 M | 38.8 M | |
| Long Term Debt To Capitalization | (5.01) | (5.27) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.